TGF-ß1 polymorphism 509 C>T is associated with an increased risk for hepatocellular carcinoma in HCV-infected patients.
Genet Mol Res
; 14(2): 4461-8, 2015 May 04.
Article
em En
| MEDLINE
| ID: mdl-25966218
Transforming growth factor-beta 1 (TGF-ß1), a member of the transforming growth factor beta family, functions as a multi-functional cytokine and plays a key role in cellular growth, proliferation, and differentiation. The 509 C/T polymorphism in the TGF-ß1 gene has been implicated in the outcome of hepatitis C virus (HCV) infection; however, little is known regarding the relationship between TGF-ß1 gene mutations and the development of hepatocellular carcinoma (HCC) in HCV-infected patients. The aim of the study was to evaluate the effect of the TGF-ß1 polymorphisms 509 C>T on the occurrence of HCC in patients chronically infected with HCV in a Chinese Han population. The results showed that HCC patients had a higher frequency of the TGF-ß1 -509 TT genotype distribution of the TGF-ß1 -509 polymorphism and a lower frequency of the CC genotype. Serum TGF-ß1 levels were significantly higher in patients with the TT genotype than in those with the CC genotype. In this study, we confirmed that the TGF-ß1 polymorphism 509 C>T is associated with the risk of HCC in HCV-infected patients.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Hepatite C
/
Carcinoma Hepatocelular
/
Predisposição Genética para Doença
/
Polimorfismo de Nucleotídeo Único
/
Fator de Crescimento Transformador beta1
/
Neoplasias Hepáticas
Tipo de estudo:
Etiology_studies
Limite:
Female
/
Humans
/
Male
/
Middle aged
Idioma:
En
Revista:
Genet Mol Res
Assunto da revista:
BIOLOGIA MOLECULAR
/
GENETICA
Ano de publicação:
2015
Tipo de documento:
Article
País de afiliação:
China
País de publicação:
Brasil